Real-world experience with posttransplant maintenance therapy in patients with myeloid neoplasms with active disease before allogeneic hematopoietic cell transplantation
Trending
- Neoadjuvant triplet chemotherapy enables radiotherapy avoidance in human papillomavirus–associated oropharyngeal cancer: a multicentre Phase II trial
- Translational modelling challenges receptor‑occupancy‑based dosing of PD‑1 inhibitors like pembrolizumab
- A pancreatic cancer organoid-macrophage co-culture using starPEG-heparin hydrogel deciphers tumor-immune cell interactions
- How Might WCLC 2026 Clarify the Evolving Role of APPs in Lung Cancer?
- How Is AI Advancing Tumor Boards, Care Coordination, and Treatment Planning?
- ITGA5 promotes homologous recombination mediated radioresistance in esophageal squamous cell carcinoma by upregulating RAD51AP1 expression
- Helping stoma bag users to swim with confidence
- Therapy induced senescence promotes immunogenicity in acute myeloid Leukemia through reduced EZH2 activity
Sunday, September 6
Real-world experience with posttransplant maintenance therapy in patients with myeloid neoplasms with active disease before allogeneic hematopoietic cell transplantation
By NewsCancer
